Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002
Phase 1
Completed
- Conditions
- Natural Blood and Blood Product Toxicity
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2022-10-20
- Lead Sponsor
- Globe Biotech Limited
- Target Recruit Count
- 42
- Registration Number
- NCT05585658
- Locations
- 🇧🇩
Globe Biotech Limited, Dhaka, Bangladesh
🇧🇩Farabi General Hospital, Dhaka, Bangladesh
News
Globe Biotech Secures First US Patent for Bangladesh with Single-Dose COVID-19 mRNA Vaccine
Globe Biotech Limited has obtained the first US pharmaceutical patent in Bangladesh's 54-year history for its COVID-19 vaccine Bangavax, marking a significant milestone for the country's pharmaceutical industry.